Introduction to CJC-1295 No DAC
CJC-1295 No DAC is a synthetic peptide analog of growth hormone-releasing hormone (GHRH) designed to stimulate the secretion of endogenous growth hormone (GH) from the pituitary gland. Unlike CJC-1295 with DAC (Drug Affinity Complex), the No DAC variant lacks the modification that prolongs half-life, resulting in a shorter duration of action and more immediate GH release.
Mechanism of Action
CJC-1295 No DAC binds to GHRH receptors in the pituitary gland, triggering GH release into circulation. This GH increase supports physiological processes such as:
Protein synthesis and muscle growth
Fat metabolism via lipolysis
Production of insulin-like growth factor 1 (IGF-1), which promotes cellular growth and regeneration
Due to its shorter half-life, CJC-1295 No DAC requires more frequent administration to maintain elevated GH levels.
Key Research Areas
Research into CJC-1295 No DAC focuses on its effects in:
Enhancing lean muscle mass and recovery
Promoting fat loss through increased lipolysis
Supporting metabolic and anabolic functions
Investigating anti-aging effects related to GH modulation
Important Notice
This compound is intended strictly for laboratory research use only. It is not approved for human use, administration, or consumption. Proper handling and safety protocols should be followed.
